OBIO vs RVTY · rev $198.0K vs P/E 42, rev $1.44B
Orchestra BioMed Holdings Inc. (OBIO) versus Revvity Inc. (RVTY) — a side-by-side from cached financials, not a winner call.
Orchestra BioMed Holdings Inc. (OBIO) is a biotechnology company listed on NASDAQ.
Revvity Inc. (RVTY) is a diagnostics & research company listed on US.
Latest reported OBIO revenue for 2026-06-30 was $198.0K. Net income was -$44.4M. Revenue was up 80.0% from 2026-03-31 to 2026-06-30. OBIO currently screens at market cap $231.7M.
Latest reported RVTY revenue for 2026-07-05 was $1.44B. Net income was $92.5M. RVTY currently screens at market cap $11.94B and trailing P/E 41.9.
OBIO currently screens at market cap $231.7M. RVTY currently screens at market cap $11.94B and trailing P/E 41.9.
Not investment advice. Open the OBIO and RVTY stock pages for the full models.
Not investment advice.